TY - JOUR
T1 - Risk of Myopericarditis After COVID-19 Vaccination in Danish Children Aged 5 to 11 Years
AU - Nygaard, Ulrikka
AU - Holm, Mette
AU - Dungu, Kia Hee Schultz
AU - Matthesen, Astrid Thaarup
AU - Stensballe, Lone Graff
AU - Espenhain, Laura
AU - Hartling, Ulla
N1 - Copyright © 2022 by the American Academy of Pediatrics.
PY - 2022/8
Y1 - 2022/8
N2 - Myopericarditis is a severe adverse event to COVID-19 vaccines.1 The highest risk has been reported in males aged 12-29 years.2-4 According to the US Vaccine Adverse Event Reporting System (VAERS), the risk in children aged 5-11 years is low with 11 reported cases following 8.7 million doses of Pfizer-BioNTech vaccine.5 However, these numbers may be underestimated due to underreporting.6.
AB - Myopericarditis is a severe adverse event to COVID-19 vaccines.1 The highest risk has been reported in males aged 12-29 years.2-4 According to the US Vaccine Adverse Event Reporting System (VAERS), the risk in children aged 5-11 years is low with 11 reported cases following 8.7 million doses of Pfizer-BioNTech vaccine.5 However, these numbers may be underestimated due to underreporting.6.
KW - COVID-19 Vaccines/adverse effects
KW - COVID-19/epidemiology
KW - Child
KW - Denmark/epidemiology
KW - Humans
KW - Myocarditis/epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85135420152&partnerID=8YFLogxK
U2 - 10.1542/peds.2022-057508
DO - 10.1542/peds.2022-057508
M3 - Letter
C2 - 35585684
SN - 0031-4005
VL - 150
SP - S66-S67
JO - Pediatrics
JF - Pediatrics
IS - 2
M1 - e2022057508
ER -